| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 72 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 72 |
| 2 | ECULIZUMAB | 50 |
| 3 | TACROLIMUS | 44 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 42 |
| 5 | TACROLIMUS OINTMENT 0.1% | 42 |
| 6 | PREDNISONE | 41 |
| 7 | MYCOPHENOLIC ACID | 28 |
| 8 | RITUXIMAB | 21 |
| 9 | EMPAGLIFLOZIN | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IPTACOPAN | 4 | 0.0050 |
| 1 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 2 | PEGCETACOPLAN | 9 | 0.0047 |
| 3 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 1 | 0.0021 |
| 4 | ECULIZUMAB | 50 | 0.0009 |
| 5 | MYCOPHENOLIC ACID | 28 | 0.0009 |
| 6 | MYCOPHENILIC ACID | 17 | 0.0008 |
| 7 | BELATACEPT | 3 | 0.0006 |
| 8 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 9 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement Inhibitor [EPC] | 56 | 0.0010 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 17 | 0.0008 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 21 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 5 | Dietary Cholesterol Absorption Inhibitor [EPC] | 17 | 0.0002 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Thiazide-like Diuretic [EPC] | 4 | 0.0001 |
| 9 | Barbiturate [EPC] | 1 | 0.0001 |